Cessation of sale process of Bush & Co.
Source: RNS
19 June 2025
NAHL Group plc
("NAHL" or the "Group")
Cessation of sale process of Bush & Co.
The Board of NAHL (AIM:NAH) advises that the process to dispose of the Group's Critical Care business, Bush & Co., has concluded without a sale. The process drew interest from a wide variety of potential bidders and the Group had lengthy discussions with and detailed proposals from two final parties, however these discussions have now ceased. The Board also concluded that neither proposal delivered appropriate value to shareholders. The Board is considering its options and will update shareholders as and when appropriate.
For further information please call:
NAHL Group PLC James Saralis (CEO) Chris Higham (CFO)
|
via FTI Consulting Tel: +44 (0) 20 3727 1000 |
Allenby Capital (AIM Nominated Adviser & Broker) Jeremy Porter / Daniel Dearden-Williams (Corporate Finance) Amrit Nahal / Stefano Aquilino (Sales & Corporate Broking)
|
Tel: +44 (0) 20 3328 5656 |
FTI Consulting (Financial PR) Alex Beagley Amy Goldup
|
Tel: +44 (0) 20 3727 1000 NAHL@fticonsulting.com |
Notes to Editors
NAHL Group plc (AIM: NAH) is a leader in the Consumer Legal Services market. The Group provides services and products to individuals and businesses through its two divisions:
· Consumer Legal Services provides outsourced marketing services to law firms through National Accident Helpline and claims processing services to individuals through National Accident Law, Law Together and Your Law. In addition, it also provides property searches through Searches UK.
· Critical Care provides a range of specialist services in the catastrophic and serious injury market to both claimants and defendants through Bush & Co.
More information is available at www.nahlgroupplc.co.uk, www.national-accident-helpline.co.uk, www.national-accident-law.co.uk and www.bushco.co.uk.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.